Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STUDY TO EVALUATE THE ROLE OF T CELL-DYSFUNCTION IN SYMPTOMS ASSOCIATED WITH LONG COVID, LYME DISEASE AND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME USING THE VIRAXIMMUNE FLUOROSPOT T CELL ASSAY

NCT06731179 is registered in ClinicalTrials.gov with ViraxBio Labs as lead sponsor.

NCT NCT06731179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06731179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STUDY TO EVALUATE THE ROLE OF T CELL-DYSFUNCTION IN SYMPTOMS ASSOCIATED WITH LONG COVID, LYME DISEASE AND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME USING THE VIRAXIMMUNE FLUOROSPOT T CELL ASSAY
Lead sponsor
ViraxBio Labs
Phase
Observational
Overall status
Active, not recruiting
Start date
December 10, 2024
Completion date
June 1, 2026
Enrollment
160 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

long covid, myalgic encephalomyelitis/chronic fatigue syndrome (me/cfs) (icd-10 g93.3), ptlds